产品名称Crizotinib (PF-02341066)

简述Inhibitors

纯化98.97%

生物活性Crizotinib an inhibitor of receptor tyrosine kinase for the treatment of non-small cell lung Y (NSCLC). Verification of the presence of ALK fusion gene is done by Abbott Molecular's Vysis ALK Break Apart FISH Probe Kit. This verification is used to select for patients suitable for treatment. FDA approved in August 26, 2011.

基因/蛋白名称ALK inhibitor; c-Met/HGFR inhibitor

CAS号877399-52-5

计算分子量450.34

配方C21H22Cl2FN5O

保存3 years -20˚C powder;2 years -80˚C in solvent;